Autophagy and neurodegeneration: when the cleaning crew goes on strike

Lancet Neurology

Volumn 6, Issue 4, 2007, Pages 352-361

  Martinez Vicente, Marta ^a   Cuervo, Ana Maria ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; POLYGLUTAMINE;

AGING; ALZHEIMER DISEASE; AUTOPHAGY; DEGENERATIVE DISEASE; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; LYSOSOME; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

AGING; ANIMALS; AUTOPHAGY; HUMANS; LYSOSOMES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; PROTEIN FOLDING; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33847652900     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70076-5     Document Type: Review

References (103)

1. De Duve C., and Wattiaux R. Functions of lysosomes. Ann Rev Physiol 28 (1966) 435-492
2. Klionsky D. The molecular machinery of autophagy: unanswered questions. J Cell Sci 118 (2005) 7-18
3. Mizushima N. The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ 12 (2005) 1535-1541
4. Levine B., and Klionsky D. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6 (2004) 463-477
5. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2 (2001) 211-216
6. Mizushima N., Yamamoto A., Hatano M., et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 152 (2001) 657-668
7. Klionsky D., Cregg J., Dunn W., et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 5 (2003) 539-545
8. Hara T., Nakamura K., Matsui M., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
9. Komatsu M., Waguri S., Chiba T., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
10. Cuervo A. Autophagy: in sickness and in health. Trends Cell Biol 14 (2004) 70-77
11. Shintani T., and Klionsky D. Autophagy in health and disease: a double-edged sword. Science 306 (2004) 990-995
12. Ogier-Denis E., and Codogno P. Autophagy: a barrier or an adaptative response to cancer. Biochim Biophys Acta 1603 (2003) 113-128
13. Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol 26 (2005) 523-528
14. Kirkegaard K., Taylor M., and Jackson W. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2 (2004) 301-314
15. Nishino I. Autophagic vacuolar myopathies. Curr Neurol Neurosci Rep 3 (2003) 64-69
16. Towns R., Kabeya Y., Yoshimori T., et al. Sera from patients with type 2 diabetes and neuropathy induce autophagy and colocalization with mitochondria in SY5Y cells. Autophagy 1 (2005) 141-145
17. Rubinsztein D., DiFiglia M., Heintz N., et al. Autophagy and its possible roles in nervous sytem diseases, damage and repair. Autophagy 1 (2005) 11-22
18. Ahlberg J., and Glaumann H. Uptake-microautophagy-and degradation of exogenous proteins by isolated rat liver lysosomes: effects of pH, ATP, and inhibitors of proteolysis. Exp Mol Pathol 42 (1985) 78-88
19. Dubouloz F., Deloche O., Wanke V., Cameroni E., and De Virgilio C. The TOR and EGO protein complexes orchestrate microautophagy in yeast. Mol Cell 19 (2005) 15-26
20. Farre J., and Subramani S. Peroxisome turnover by micropexophagy: an autophagy-related process. Trends Cell Biol 14 (2004) 515-523
21. Dice J. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 15 (1990) 305-309
22. Majeski A., and Dice J. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 36 (2004) 2435-2444
23. Massey A., Zhang C., and Cuervo A. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 73 (2006) 205-235
24. Cuervo A., and Dice J. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273 (1996) 501-503
25. Kiffin R., Christian C., Knecht E., and Cuervo A. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 15 (2004) 4829-4840
26. Cuervo A., Hildebrand H., Bomhard E., and Dice J. Direct lysosomal uptake of alpha2-microglobulin contributes to chemically induced nephropathy. Kidney Int 55 (1999) 529-545
27. Sooparb S., Price S., Shaoguang J., and Franch H. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 65 (2004) 2135-2144
28. Cuervo A., Stefanis L., Fredenburg R., Lansbury P., and Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305 (2004) 1292-1295
29. Markossian K., and Kurganov B. Protein folding, misfolding, and aggregation: formation of inclusion bodies and aggresomes. Biochemistry (Mosc) 69 (2004) 971-984
30. Esser C., Alberti S., and Hohfeld J. Cooperation of molecular chaperones with the ubiquitin/proteasome system. Biochim Biophys Acta 1695 (2004) 171-188
31. Imai J., Yashiroda H., Maruya M., Yahara I., and Tanaka K. Proteasomes and molecular chaperones: cellular machinery responsible for folding and destruction of unfolded proteins. Cell Cycle 2 (2003) 585-590
32. Goldberg A. Protein degradation and protection against misfolded or damaged proteins. Nature 18 (2003) 895-899
33. McClellan A., Tam S., Kaganovich D., and Frydman J. Protein quality control: chaperones culling corrupt conformations. Nat Cell Biol 7 (2005) 736-741
34. Slow E., Graham R., and Hayden M. To be or not to be toxic: aggregations in Huntington and Alzheimer disease. Trends Genet 22 (2006) 408-411
35. Scheibel T., and Buchner J. Protein aggregation as a cause for disease. Handb Exp Pharmacol 172 (2006) 199-219
36. Rubinsztein D., and Huntington J. Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragments. Exp Neurol 199 (2006) 243-244
37. Cuervo A. Autophagy in neurons: it is not all about food. Trends Mol Med 12 (2006) 461-464
38. Bennett E., Bence N., Jayakumar R., and Kopito R. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 17 (2005) 351-365
39. Massey A., Kaushik S., Sovak G., Kiffin R., and Cuervo A. Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci USA 103 (2006) 5805-5810
40. Iwata A., Riley B., Johnston J., and Kopito R. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280 (2005) 40282-40292
41. Ravikumar B., Vacher C., Berger Z., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36 (2004) 585-595
42. Pollanen M., Dickson D., and Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52 (1993) 183-191
43. Nussbaum R., and Polymeropoulos M. Genetics of Parkinson's disease. Hum Mol Genet 6 (1997) 1687-1691
44. Abou-Sleiman P., Muqit M., and Wood N. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 7 (2006) 207-219
45. Betarbet R., Sherer T., and Greenamyre J. Ubiquitin-proteasome system and Parkinson's diseases. Exp Neurol 191 suppl 1 (2005) S17-S27
46. Zarranz J., Alegre J., Gomez-Esteban J., et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55 (2004) 164-173
47. Singleton A., Farrer M., Johnson J., et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
48. Conway K., Lee S., Rochet J., Ding T., Williamson R., and Lansbury Jr. P. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97 (2000) 571-576
49. Rochet J., Outeiro T., Conway K., et al. Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. J Mol Neurosci 23 (2004) 23-34
50. Norris E., Giasson B., Hodara R., et al. Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J Biol Chem 280 (2005) 21212-21219
51. Kahle P., Neumann M., Ozmen L., et al. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J Neurosci 20 (2000) 6365-6373
52. Abeliovich A., Schmitz Y., Farinas I., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000) 239-252
53. Chandra S., Gallardo G., Fernandez-Chacon R., Schluter O., and Sudhof T. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123 (2005) 383-396
54. Lashuel H., Hartley D., Petre B., Walz T., and Lansbury Jr. P. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418 (2002) 291
55. Webb J., Ravikumar B., Atkins J., Skepper J., and Rubinsztein D. Alpha-synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278 (2003) 25009-25013
56. Stefanis L., Larsen K., Rideout H., Sulzer D., and Greene L. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21 (2001) 9549-9560
57. Rideout H., Lang-Rollin I., and Stefanis L. Involvement of macroautophagy in the dissolution of neuronal inclusions. Int J Biochem Cell Biol 36 (2004) 2551-2562
58. Norris E., and Giasson B. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders. Antioxid Redox Signal 7 (2005) 672-684
59. Martinez-Vicente M., Sovak G., and Cuervo A. Protein degradation and aging. Exp Gerontol 40 (2005) 622-633
60. Mitsumoto A., and Nakagawa Y. DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res 35 (2001) 885-893
61. Valente E., Abou-Sleiman P., Caputo V., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
62. Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1995) 605-608
63. McNaught K., Mytilineou C., Jnobaptiste R., et al. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 81 (2002) 301-306
64. Ramirez A., Heimbach A., Grundemann J., et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38 (2006) 1184-1191
65. Clark I., Dodson M., Jiang C., et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441 (2006) 1162-1166
66. Park J., Lee S., Lee S., et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441 (2006) 1157-1161
67. Ikeuchi T., Dolios G., Kim S., Wang R., and Sisodia S. Familial Alzheimer disease-linked presenilin 1 variants enhance production of both Abeta 1-40 and Abeta 1-42 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of "gamma-secretase". J Biol Chem 278 (2003) 7010-7018
68. Glabe C., and Kayed R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66 2 suppl 1 (2006) S74-S78
69. Lue L., Kuo Y., Roher A., et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155 (1999) 853-862
70. Oh S., Hong H., Hwang E., et al. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev 126 (2005) 1292-1299
71. Blandini F., Sinforiani E., Pacchetti C., et al. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology 66 (2006) 529-534
72. Nixon R., Wegiel J., Kumar A., et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64 (2005) 113-122
73. Cataldo A., Barnett J., Berman S., et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14 (1995) 671-680
74. Yu W., Cuervo A., Kumar A., et al. Macroautophagy: a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 171 (2005) 87-98
75. Pattingre S., and Levine B. Bcl-2 inhibition of autophagy: a new route to cancer?. Cancer Res 66 (2006) 2885-2888
76. Landles C., and Bates G. Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep 5 (2004) 958-963
77. Ambrose C., Duyao M., Barnes G., et al. Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 20 (1994) 27-38
78. Kegel K., Kim M., Sapp E., et al. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20 (2000) 7268-7278
79. Li S., and Li X. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 20 (2004) 146-154
80. Cha J. Transcriptional dysregulation in Huntington's disease. Trends Neurosci 23 (2000) 387-392
81. Gidalevitz T., Ben-Zvi A., Ho K., Brignull H., and Morimoto R. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311 (2006) 1471-1474
82. Arrasate M., Mitra S., Schweitzer E., Segal M., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
83. Taylor J., Tanaka F., Robitschek J., et al. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet 12 (2003) 749-757
84. Slow E., Graham R., Osmand A., et al. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci USA 102 (2005) 11402-11407
85. Sakahira H., Breuer P., Hayer-Hartl M., and Hartl F. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci USA 99 suppl 4 (2002) 16412-16418
86. Diaz-Hernandez M., Valera A., Moran M., et al. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. J Neurochem 98 (2006) 1585-1596
87. Ravikumar B., Duden R., and Rubinsztein D. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11 (2002) 1107-1117
88. Qin Z., Wang Y., Kegel K., et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 12 (2003) 3231-3244
89. Shibata M., Lu T., Furuya T., et al. Regulation of intracellular accumulation of mutant huntingtin by Beclin 1. J Biol Chem 281 (2006) 14474-14485
90. Schmelzle T., and Hall M. TOR, a central controller of cell growth. Cell 103 (2000) 253-262
91. Cuervo A., Bergamini E., Brunk U., Droge W., Ffrench M., and Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 1 (2005) 131-140
92. Ward W. Protein degradation in the aging organism. Prog Mol Subcell Biol. 29 (2002) 35-42
93. Ferrington D., Husom A., and Thompson L. Altered proteasome structure, function and oxidation in aged muscle. FASEB J 19 (2005) 644-646
94. Gray D., Tsirigotis M., and Woulfe J. Ubiquitin, proteasomes, and the aging brain. Sci Aging Knowledge Environ 34 (2003) RE6
95. Bergamini E., Cavallini G., Donati A., and Gori Z. The role of macroautophagy in the ageing process, anti-ageing intervention and age-associated diseases. Int J Biochem Cell Biol 36 (2004) 2392-2404
96. Terman A. The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocyte. Gerontology 41 (1995) 319-325
97. Cuervo A., and Dice J. Age-related decline in chaperone-mediated autophagy. J Biol Chem 275 (2000) 31505-31513
98. Kiffin R., Kaushik S., Zeng M., et al. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J Cell Sci 120 (2007) 782-791
99. Berger Z., Ravikumar B., Menzies F., et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 15 (2006) 433-442
100. Ravikumar B., Acevedo-Arozena A., Imarisio S., et al. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat Genet 37 (2005) 771-776
101. Sarkar S., Floto R., Berger Z., et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170 (2005) 1101-1111
102. Donati A., Cavallini G., Carresi C., Gori Z., Parentini I., and Bergamini E. Anti-aging effects of anti-lipolytic drugs. Exp Gerontol 39 (2004) 1061-1067
103. Bergamini E., Cavallini G., Donati A., and Gori Z. The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically. Biomed Pharmacother 53 (2003) 203-208